García-González Ana Isabel, Axtle-Serrano Zoraida, López-Teros Miriam, Szlejf Claudia, Martínez-Ruiz Adrián, Rosas-Carrasco Oscar
Secretaría de Salud, Instituto Nacional de Geriatría, Departamento de Investigación en Epidemiología Clínica. Ciudad de México, México
Rev Med Inst Mex Seguro Soc. 2018;56(Suppl 1):S82-S93.
Osteosarcopenic obesity (OSO) is a condition associated with adverse outcomes in older adults. Since it is a condition which includes three tissues (obesity, sarcopenia and osteopenia/osteoporosis), it requires simultaneous and multidisciplinary clinical interventions to revert it. Until this moment, there have been published review articles only focused on nutrition or physical activity. However, we believe that assembling the existing evidence on potential treatments (nutritional intervention with micro- and macronutrients), physical activity, farmacological treatment for osteopenia/osteoporosis, possible farmacological treatment for sarcopenia, and, finally, psychological interventions focused on the treatment of psychiatric comorbidities (such as anxiety or depression) will help healthcare providers to improve the body composition of older adults.
骨肌少性肥胖（OSO）是一种与老年人不良预后相关的病症。由于它是一种涉及三种组织（肥胖、肌少症和骨质减少/骨质疏松症）的病症，因此需要同时进行多学科临床干预才能使其逆转。到目前为止，已发表的综述文章仅关注营养或体育活动。然而，我们认为，汇总有关潜在治疗方法（微量和常量营养素的营养干预）、体育活动、骨质减少/骨质疏松症的药物治疗、肌少症可能的药物治疗，以及最后针对精神共病（如焦虑或抑郁）治疗的心理干预的现有证据，将有助于医疗保健提供者改善老年人的身体组成。
